Aier Eye Hospital Group Co Ltd
Research Aier Eye Hospital Group Co Ltd (300015.SZ) on Bullrun: market cap CNY 80.74B, P/E 33.5, dividend yield 2.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker300015.SZ
- ExchangeSZ
- CountryChina
- SectorHealthcare
- IndustryMedical Care Facilities
- CurrencyCNY
- Market capCNY 80.74B
- P/E33.5
- Dividend yield2.1%
- Financial periodQ2 2026
- RevenueCNY 5.55B
- Net incomeCNY 176.45M
- Free cash flowCNY 917.37M
- Gross margin44.3%
Valuation Snapshot
latest market cap is CNY 80.74B; P/E is 33.5; dividend yield is 2.1%.
Peer valuation comparison
Latest P/E is 33.46x versus a Healthcare sector median of 21.8x (53.5% above).
Latest dividend yield is 2.08% versus a Healthcare sector median of 2.4% (13.3% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-11-11 | CNY 80.74B | 33.5 | 2.0% | 0.18 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.18 CNY, yield 2.1%.
About Aier Eye Hospital Group Co Ltd
Aier Eye Hospital Group Co., Ltd. operates as an ophthalmic medical company in China, Hong Kong, Europe, the United States, and Southeast Asia. It offers diagnosis and treatment services for various ophthalmic diseases, and surgical and medical optometry services, as well as lens fitting services for fundus diseases, glaucoma, and cataract. The company also provides training courses for cataract cases, ICL surgery, and presbyopia surgery. Aier Eye Hospital Group Co., Ltd.
ETFs that hold Aier Eye Hospital Group Co Ltd
US-listed ETFs
Aier Eye Hospital Group Co Ltd is held by 40 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| iShares MSCI Emerging Markets ETF (EEM) | 0.01% | 0.72% |
| iShares Core MSCI Emerging Markets ETF (IEMG) | 0.01% | 0.09% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | 0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| iShares MSCI ACWI ETF (ACWI) | <0.01% | 0.32% |
| iShares MSCI ACWI ex U.S. ETF (ACWX) | <0.01% | 0.32% |
| Vanguard FTSE All-World ex-US Index Fund ETF Shares (VEU) | <0.01% | 0.04% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Aier Eye Hospital Group Co Ltd's market cap?
Aier Eye Hospital Group Co Ltd's market capitalization is CNY 80.74B.
What is Aier Eye Hospital Group Co Ltd's P/E ratio?
Aier Eye Hospital Group Co Ltd's price-to-earnings (P/E) ratio is 33.5.
Does Aier Eye Hospital Group Co Ltd pay a dividend?
Aier Eye Hospital Group Co Ltd has a dividend yield of 2.1%.
What does Aier Eye Hospital Group Co Ltd do?
Aier Eye Hospital Group Co., Ltd. operates as an ophthalmic medical company in China, Hong Kong, Europe, the United States, and Southeast Asia. It offers diagnosis and treatment services for various ophthalmic diseases, and surgical and medical optometry services, as well as lens fitting services for fundus diseases, glaucoma, and cataract. The company also provides training courses for cataract cases, ICL surgery, and presbyopia surgery. Aier Eye Hospital Group Co., Ltd. was founded in 2002 and is headquartered in Changsha, China.